- Home
- PAMT vs TECX Comparison
PAMT vs TECX Comparison
Compare PAMT & TECX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAMT
- TECX
- Stock Information
- Founded
- PAMT 1980
- TECX 2019
- Country
- PAMT United States
- TECX United States
- Employees
- PAMT N/A
- TECX N/A
- Industry
- PAMT Trucking Freight/Courier Services
- TECX
- Sector
- PAMT Industrials
- TECX
- Exchange
- PAMT Nasdaq
- TECX Nasdaq
- Market Cap
- PAMT 293.5M
- TECX 311.3M
- IPO Year
- PAMT 1985
- TECX 2018
- Fundamental
- Price
- PAMT $14.18
- TECX $17.02
- Analyst Decision
- PAMT Hold
- TECX Strong Buy
- Analyst Count
- PAMT 1
- TECX 5
- Target Price
- PAMT $16.50
- TECX $77.75
- AVG Volume (30 Days)
- PAMT 41.1K
- TECX 264.6K
- Earning Date
- PAMT 04-29-2025
- TECX 05-24-2025
- Dividend Yield
- PAMT N/A
- TECX N/A
- EPS Growth
- PAMT N/A
- TECX N/A
- EPS
- PAMT N/A
- TECX N/A
- Revenue
- PAMT $714,646,000.00
- TECX N/A
- Revenue This Year
- PAMT $0.61
- TECX N/A
- Revenue Next Year
- PAMT $10.29
- TECX N/A
- P/E Ratio
- PAMT N/A
- TECX N/A
- Revenue Growth
- PAMT N/A
- TECX N/A
- 52 Week Low
- PAMT $11.01
- TECX $1.40
- 52 Week High
- PAMT $23.70
- TECX $61.07
- Technical
- Relative Strength Index (RSI)
- PAMT N/A
- TECX 39.69
- Support Level
- PAMT N/A
- TECX $15.96
- Resistance Level
- PAMT N/A
- TECX $18.49
- Average True Range (ATR)
- PAMT 0.00
- TECX 1.67
- MACD
- PAMT 0.00
- TECX 0.55
- Stochastic Oscillator
- PAMT 0.00
- TECX 67.21
About PAMT PAMT CORP Common Stock
PAMT Corp is a holding company that is engaged in providing truckload dry van carriers transporting general commodities throughout the continental United States, as well as the Canadian provinces of Ontario and Quebec. It has one reportable segment being motor carrier.
About TECX Tectonic Therapeutic Inc. Common Stock
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.